DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,227,000 | +9.9% | 56,963 | +8.8% | 0.30% | +10.1% |
| Q2 2019 | $7,486,000 | +56.0% | 52,374 | +44.1% | 0.28% | +41.5% |
| Q1 2019 | $4,799,000 | +41.7% | 36,352 | +10.7% | 0.20% | +28.3% |
| Q4 2018 | $3,387,000 | -1.9% | 32,844 | +3.4% | 0.15% | +21.6% |
| Q3 2018 | $3,452,000 | -3.2% | 31,765 | -12.1% | 0.12% | -11.3% |
| Q2 2018 | $3,565,000 | +11.7% | 36,124 | +10.8% | 0.14% | +5.2% |
| Q1 2018 | $3,192,000 | +3.3% | 32,603 | -2.1% | 0.13% | +2.3% |
| Q4 2017 | $3,090,000 | +32.3% | 33,289 | +22.3% | 0.13% | +20.2% |
| Q3 2017 | $2,336,000 | -11.2% | 27,230 | -12.7% | 0.11% | -16.8% |
| Q2 2017 | $2,631,000 | -1.8% | 31,180 | -0.5% | 0.13% | -10.9% |
| Q1 2017 | $2,679,000 | -15.0% | 31,324 | -22.6% | 0.15% | -24.2% |
| Q4 2016 | $3,151,000 | -10.8% | 40,480 | -10.2% | 0.19% | -14.5% |
| Q3 2016 | $3,532,000 | -98.4% | 45,059 | -97.9% | 0.23% | -93.4% |
| Q2 2016 | $219,178,000 | +1212.3% | 2,176,943 | +1136.4% | 3.44% | +1355.9% |
| Q1 2016 | $16,702,000 | -51.5% | 176,064 | -52.5% | 0.24% | -53.0% |
| Q4 2015 | $34,440,000 | +1.5% | 370,825 | -6.9% | 0.50% | -6.3% |
| Q3 2015 | $33,937,000 | +103.3% | 398,274 | +104.2% | 0.54% | +112.7% |
| Q2 2015 | $16,696,000 | +1.3% | 195,061 | +0.4% | 0.25% | +1.2% |
| Q1 2015 | $16,489,000 | -1.1% | 194,207 | -0.2% | 0.25% | -1.6% |
| Q4 2014 | $16,675,000 | +15.3% | 194,544 | +2.2% | 0.25% | +1.6% |
| Q3 2014 | $14,465,000 | -1.5% | 190,352 | +2.1% | 0.25% | -9.5% |
| Q2 2014 | $14,687,000 | +2.6% | 186,524 | -2.3% | 0.28% | -12.4% |
| Q1 2014 | $14,315,000 | -53.2% | 190,832 | -51.8% | 0.31% | -26.6% |
| Q4 2013 | $30,556,000 | +151.9% | 395,816 | +126.2% | 0.43% | +8.6% |
| Q3 2013 | $12,132,000 | +7.7% | 175,000 | -1.7% | 0.39% | +5.6% |
| Q2 2013 | $11,268,000 | – | 178,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |